ADMA BIOLOGICS, INC. (ADMA) Gross profit 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual gross profit history from SEC filings — each fiscal year as reported.
$292.8MFY2025 · since FY2016: $4.3M → $292.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $292.8M | +33.3% |
| FY2024 | $219.6M | +146.8% |
| FY2023 | $88.9M | +152.2% |
| FY2022 | $35.3M | +2906.4% |
| FY2021 | $1.2M | +106.2% |
| FY2020 | -$19.1M | -87.8% |
| FY2019 | -$10.2M | +59.7% |
| FY2018 | -$25.2M | -293.7% |
| FY2017 | -$6.4M | -248.9% |
| FY2016 | $4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADMA financial trends
ADMA RevenueADMA Net incomeADMA Net marginADMA Gross marginADMA Operating incomeADMA Operating marginADMA Operating cash flowADMA Free cash flowADMA Capital expendituresADMA Return on equityADMA Stock buybacksADMA Dividends paidADMA Total assetsADMA Total liabilitiesADMA Shareholders’ equityADMA overview →